France· FR:63239234
TIBSOVO 250 mg, comprimé pelliculé
A medicinal product containing ivosidénib, registered in France by LES LABORATOIRES SERVIER, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IVOSIDÉNIB
- Manufacturer
- LES LABORATOIRES SERVIER
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302715991 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimésEUR 11.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ivosidénib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTibsovo 250 mgLes Laboratoires Servier
- SwitzerlandTibsovo 250 mg, comprimés pelliculésServier (Suisse) SA
- CzechiaTIBSOVOLes Laboratoires Servier, Suresnes cedex
- SpainTIBSOVO 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- FinlandTibsovoLes Laboratoires Servier
- IrelandTibsovo 250 mg Film-coated tabletLes Laboratoires Servier
- IcelandTibsovoLes Laboratoires Servier*
- NetherlandsTibsovo 250 mg, filmomhulde tablettenLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tibsovo
- Liechtenstein · Tibsovo
- Norway · Tibsovo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebd2e922-f168-45d9-a9ef-f41e2da69ee8 GET /v1/drugs/ebd2e922-f168-45d9-a9ef-f41e2da69ee8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63239234",
"date_amm": "2023-05-04",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/23/1728",
"substance": "IVOSIDÉNIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about ivosidénib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.